iRadimed IRMD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $22.48M+16.9% | $19.23M+11.9% | $17.19M+34.0% | $12.83M+37.6% | ||
| $1.17M+42.5% | $818K+6.9% | $765.18K— | —— | ||
| $2.92M+15.6% | $2.52M+15.4% | $2.19M+56.9% | $1.39M-8.1% | ||
| -$2.73M— | —— | $1.17M+2,152% | -$57.1K+89.1% | ||
| -$84K+11.6% | -$95K— | —— | $102.77K+641% | ||
| —— | —— | —— | $8.24M+1,332% | ||
| $1.43M+146% | -$3.13M-142% | $7.47M+471% | $1.31M— | ||
| -$76K— | —— | -$216.44K-119% | $1.12M+3,599% | ||
| —— | $997K— | —— | —— | ||
| $132K-58.8% | $320K-43.1% | $562.49K+284% | -$305.94K— | ||
| —— | -$100K— | —— | -$146.44K— | ||
| $1.6M— | —— | $615.64K+16.0% | $530.58K— | ||
| —— | -$786.05K— | —— | $3.34M+482% | ||
| $24.95M-2.6% | $25.62M+90.3% | $13.47M+34.1% | $10.04M-10.8% | ||
| $7.77M-3.0% | $8.01M+7.6% | $7.44M+804% | $823.02K+70.6% | ||
| —— | —— | —— | —— | ||
| -$8.42M+4.5% | -$8.82M-10.1% | -$8.01M-451% | -$1.45M— | ||
| $15.04M+10.0% | $13.68M— | —— | —— | ||
| $2.56M+272% | $688K+12.7% | $610.35K+108% | $293.98K-50.9% | ||
| -$17.6M-22.8% | -$14.34M-5.0% | -$13.66M-7.0% | -$12.76M-52,336% | ||
| -$1.08M-143% | $2.47M— | —— | —— | ||
| $3.92M-39.8% | $6.51M— | —— | $1.71M— | ||
| -$2.73M— | —— | $1.17M+2,152% | -$57.1K+89.1% | ||
| —— | $997K— | —— | —— | ||
| —— | -$100K— | —— | -$146.44K— | ||
| $41.41K— | —— | —— | —— | ||
| $132K-58.8% | $320K-43.1% | $562.49K+284% | -$305.94K— | ||
| $2.58M+228% | $786K— | —— | —— | ||
| —— | —— | -$18.7K-1.6% | -$18.4K-151% | ||
| $47K— | —— | —— | $55.74K-53.3% | ||
| -$84K+11.6% | -$95K— | —— | $102.77K+641% | ||
| —— | —— | —— | —— | ||
| $1.6M— | —— | $615.64K+16.0% | $530.58K— | ||
| $3.92M-39.8% | $6.51M— | —— | $1.71M— | ||
| $17.18M-2.5% | $17.62M+192% | $6.02M-34.7% | $9.22M-14.4% | ||
| $17.18M-2.5% | $17.62M+192% | $6.02M-34.7% | $9.22M-14.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does iRadimed generate?
- iRadimed (IRMD) generated $28.9M in operating cash flow over the trailing twelve months.
- What is iRadimed's free cash flow?
- After $4.5M of capital expenditures, iRadimed's free cash flow was $24.5M over the trailing twelve months, up 67.6% year over year.
- Where does iRadimed's cash flow data come from?
- Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
